141 related articles for article (PubMed ID: 29165836)
1. Morbihan disease treated with Tripterygium wilfordii successfully.
Yu X; Qu T; Jin H; Fang K
J Dermatol; 2018 May; 45(5):e122-e123. PubMed ID: 29165836
[No Abstract] [Full Text] [Related]
2. Morbihan Disease Treatment: Two Case Reports and a Systematic Literature Review.
Boparai RS; Levin AM; Lelli GJ
Ophthalmic Plast Reconstr Surg; 2019; 35(2):126-132. PubMed ID: 30252748
[TBL] [Abstract][Full Text] [Related]
3. [Advances in studies compatibility applied toattenuation and synergy of Tripterygium wilfordii].
Rao Y; Wei HZ; Chen YF; Fang HH; Zhu SS; Wu YG; Zhang J
Zhongguo Zhong Yao Za Zhi; 2008 Jul; 33(14):1658-61. PubMed ID: 18841759
[TBL] [Abstract][Full Text] [Related]
4. [Morbihan disease--chronic persistent erythema and edema of the face].
Hölzle E; Jansen T; Plewig G
Hautarzt; 1995 Nov; 46(11):796-8. PubMed ID: 8641887
[TBL] [Abstract][Full Text] [Related]
5. [Effect of Tripterygium wilfordii on gonadal injury and progression of its relative Chinese medicine therapy].
Li Z; Wang Z; Gong C
Zhongguo Zhong Yao Za Zhi; 2009 May; 34(9):1067-70. PubMed ID: 19685735
[TBL] [Abstract][Full Text] [Related]
6. [An observation of the percutaneous absorption of total alkaloids and terpenoid lactones of Tripterygium wilfordii].
Peng D; Liu Q; Zhao Z; Huang W; Qiu J
Zhong Yao Cai; 1997 Oct; 20(10):524-7. PubMed ID: 12572524
[TBL] [Abstract][Full Text] [Related]
7. [Studies on caulis Tripterygium wilfordii and hypothalamus-pituitary-adrenal gland].
Chen L; Huang GZ
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2001 Aug; 21(8):633-5. PubMed ID: 12575582
[No Abstract] [Full Text] [Related]
8. Rosaceous lymphedema: a rare variant of a common disorder.
Harvey DT; Fenske NA; Glass LF
Cutis; 1998 Jun; 61(6):321-4. PubMed ID: 9640553
[TBL] [Abstract][Full Text] [Related]
9. Triptolide: progress on research in pharmacodynamics and toxicology.
Li XJ; Jiang ZZ; Zhang LY
J Ethnopharmacol; 2014 Aug; 155(1):67-79. PubMed ID: 24933225
[TBL] [Abstract][Full Text] [Related]
10. [Progress in Tripterygium wilfordiiand its bioactive components in the field of pharmacodynamics and pharmacology].
Shui G; Wan Y; Jiang C; Zhang H; Chen P; Wang C; Yao J
Zhongguo Zhong Yao Za Zhi; 2010 Feb; 35(4):515-20. PubMed ID: 20450057
[TBL] [Abstract][Full Text] [Related]
11. Extreme Eyelid Lymphedema Associated With Rosacea (Morbihan Disease): Case Series, Literature Review, and Therapeutic Considerations.
Carruth BP; Meyer DR; Wladis EJ; Bradley EA; Al-Rohil R; Jones DM; Bartley GB
Ophthalmic Plast Reconstr Surg; 2017; 33(3S Suppl 1):S34-S38. PubMed ID: 26505236
[TBL] [Abstract][Full Text] [Related]
12. [The investigation and progress of the cellular and molecular biological mechanisms of Tripterygium wilfordii in treating rheumatoid arthritis].
Chen Z; Li RL; Tu SH
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2009 Feb; 29(2):183-6. PubMed ID: 19382484
[No Abstract] [Full Text] [Related]
13. [Toxicity attenuation and efficacy potentiation effect of liquorice on treatment of rheumatoid arthritis with Tripterygium wilfordii].
Li YS; Tong PJ; Ma HZ
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2006 Dec; 26(12):1117-9. PubMed ID: 17205826
[TBL] [Abstract][Full Text] [Related]
14. Morbihan disease: a therapeutic challenge.
Cabral F; Lubbe LC; Nóbrega MM; Obadia DL; Souto R; Gripp AC
An Bras Dermatol; 2017; 92(6):847-850. PubMed ID: 29364446
[TBL] [Abstract][Full Text] [Related]
15. [Research and prospect on reducing the toxicity and enhancing the efficacy of Tipterygium wilfordii by combined use of Chinese medicine].
Li B; Zhou XX; Liang MX
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2006 Nov; 26(11):1045-8. PubMed ID: 17186742
[TBL] [Abstract][Full Text] [Related]
16. Four cases of Morbihan disease successfully treated with doxycycline.
Okubo A; Takahashi K; Akasaka T; Amano H
J Dermatol; 2017 Jun; 44(6):713-716. PubMed ID: 28150340
[TBL] [Abstract][Full Text] [Related]
17. Successful treatment with long-term use of minocycline for Morbihan disease showing mast cell infiltration: A second case report.
Kabuto M; Fujimoto N; Honda S; Tanaka T
J Dermatol; 2015 Aug; 42(8):827-8. PubMed ID: 25917342
[No Abstract] [Full Text] [Related]
18. New abietane-type diterpene glycosides from the roots of Tripterygium wilfordii.
Li HM; Wan DW; Li RT
J Asian Nat Prod Res; 2015; 17(7):761-6. PubMed ID: 25588600
[TBL] [Abstract][Full Text] [Related]
19. [Effect of Tripterygium wilfordii glycosides combined with gestrinone on endometriosis and serum cytokine expression].
Zhou XH; Fu WJ; Wang BD; Fu QX
Zhongguo Zhong Yao Za Zhi; 2016 Sep; 41(18):3478-3482. PubMed ID: 28925135
[TBL] [Abstract][Full Text] [Related]
20. Tripterygium wilfordii Inhibiting Angiogenesis for Rheumatoid Arthritis Treatment.
Zhang W; Li F; Gao W
J Natl Med Assoc; 2017 Summer; 109(2):142-148. PubMed ID: 28599756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
